Investment Q&A

Q: What are thoughts on the recent quarter, seems the market is scared of a another disaster restructuring deal that BXE is doing.

Anything positive in the quarter worth hanging on to?
Thanks

Q: Hi team,
PLI took a deep dive today. Any particular reason why? I sold them at a loss a couple of months ago and wondered if it's worth getting back in once they hit bottom. I keep thinking there may be money to be made with this stock. Have they hit a bottom or do you think there is still some downside?
Thanks

Q: I am interested in buying the shares of LJPC, considering its huge drop and the potential of good renounce, would you please share your idea about this?

Q: Do you think the proposed nomination of the new directors gets approved by share holders ?
If so, could the new board replace Mr. Goodman.
Can you elaborate as to what is most likely to happen in the next few months ?
Thanks for your advice.

Q: I would like to know if there is any "hanky panky" going on with
SIS and Dejardins. SIS got upgraded by Dejardins from $16 to $17.50 on an earnings miss which made the stock go up over $15. Now Dejardins are the underwriters
of this deal. Also does this type of "you scratch my back and I'll scratch yours"
happen often in the markets?

Q: Medison(7.3% shareholder) is nominating 6 (qualified members per co) plus its CEO(existing director) to the board of GUD(total 7 seats).Maybe this will result in positive price action for long suffering investors who bought in the $10 range.Your comment please.Thanks for u usual great services & views

Q: What are your thoughts on the bought deal private placement of 5M shares? If this was a less common occurrence it would be acceptable but SIS just raised money last year. On both occasions they wait for the share price to get to around $15/$16 and they decide to raise money and drive the share price down. They have set a ceiling on the share price and everytime it gets momentum they send it falling back down to earth. It seems to me that they raise the dividend to drive up the share price only to dilute our shares to get more money. If you need money why raise the dividend 20%, why not keep it the same or slight raise to save money and stop diluting and let the share price go above $16. I've liked mgmt but I'm starting to lose confidence in their decisions around growth. They have just ensured that the share price will fall to $14 tomorrow and stay in that range for months to come. Same as last year. Sorry, frustrated with the recurring dilution. Thanks

Q: Follow-up on my earlier post today relevant to a possible reason for COVALON's 10% jump in stock price: The Zacks report a COV director sent to investors this morning (as an email attachment) is dated: March 18, 2019, and was authored by Brian Marckx, CFA, with Zacks Small Cap Research. While there may be an old Zacks report out there, this one appears to be new.

Q: Jeffrey Mandel (a director on Covalon's Board) sent one of his periodic e-mails directly to COV investors. Today's message included a PDF attachment of a 25pp research document COV apparently commissioned from Zacks Small Cap Research in Chicago. Unsurprisingly, the analysis is glowing, which stated, in part, "We forecast Covalon to generate revenue and EPS of C$53.4M and C$0.13 in 2019 and C$64.5M and C$0.30 in 2020. We value Covalon using a combination of P/S and P/E methodologies. Based on analyst's revenue and EPS estimates of publicly traded companies in focused on wound care and medical supplies, infection control and vascular products, we calculate fair value of Covalon at ~C$11.2/share, or US$8.50 based on current exchange rates."

Q: Hi Team,

Could you tell us the story behind today's 10% jump please.

Thanks!

Q: What is your opinion on VRTX?

Q: In reference to your answer to Roy on March 29. While I appreciate your answer to the question asked, it leaves me as an existing stockholder wondering if you are implying a sell recommendation above $15.00
Hope you understand my thought on this.
Thanks
John

Q: Put in an order to SIS this am. It ran away from me. Based on valuation what would you consider a fair bid for this stock?

Q: $17.28p/p, now 3.5% position. Positive market response to Q results even though missed estimated eps. Is it time for me to add? Thanks for u usual great services & views

Q: With the new agreement with Glencore how do you feel about the future of NIF.UN? What has to happen to restart the dividend?
I would appreciate your thoughts on PRN also.
Thank you,
Bob

Q: May I have your opinion on the latest results? Thank you.

Q: IRTC has plunged today.. what has caused this?

Thanks,
Susan

Q: I own 6800 shares of Knight at an average cost of $8.10. This amounts to about 2% of my portfolio. I could sell it all, sell half or do nothing. What do you see for Knight in the next 5 years. Should I be looking elsewhere? Thank You.

Q: do you have a opinion on VCAN, previously BLVD, and before that CXV. It has gone through several transformations do you like the current version and what are it's prospects ? Is it worth a gamble? If you have a favourable opinion how long to wait before seeing results.

Thank you

Q: Hi! I was wondering if you recommend SIS (Savaria) before their earnings on the 27th, or if you have an opinion on it. I bought at 13.07 last week, but I am a bit nervous about a drop come their earnings. Any thought you have on it would be appreciated!